BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15564966)

  • 1. Treatment of rebound pulmonary hypertension: why not sildenafil?
    Raja SG
    Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
    [No Abstract]   [Full Text] [Related]  

  • 2. Sildenafil treatment of primary pulmonary hypertension.
    Laupland KB; Helmersen D; Zygun DA; Viner SM
    Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.
    Porta NF; Steinhorn RH
    Clin Perinatol; 2012 Mar; 39(1):149-64. PubMed ID: 22341543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.
    De Luca D; Zecca E; Vento G; De Carolis MP; Romagnoli C
    Paediatr Anaesth; 2006 May; 16(5):597-8. PubMed ID: 16677275
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination of sildenafil and bosentan for nitric oxide withdrawal.
    Behrends M; Beiderlinden M; Peters J
    Eur J Anaesthesiol; 2005 Feb; 22(2):155-7. PubMed ID: 15816597
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. A combination treatment for pulmonary hypertension.
    Ann Intern Med; 2008 Oct; 149(8):I-38. PubMed ID: 18936497
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
    Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
    Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil for pulmonary hypertension in pregnancy?
    Lynch TD; Laffey JG
    Anesthesiology; 2006 Feb; 104(2):382; author reply 383. PubMed ID: 16436871
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children.
    Namachivayam P; Theilen U; Butt WW; Cooper SM; Penny DJ; Shekerdemian LS
    Am J Respir Crit Care Med; 2006 Nov; 174(9):1042-7. PubMed ID: 16917115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
    Jue VI
    Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
    [No Abstract]   [Full Text] [Related]  

  • 14. Sildenafil can increase the response to inhaled nitric oxide.
    Bigatello LM; Hess D; Dennehy KC; Medoff BD; Hurford WE
    Anesthesiology; 2000 Jun; 92(6):1827-9. PubMed ID: 10839936
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?
    Florez ID; Parra-Rodas L
    Crit Care Med; 2024 Jun; 52(6):995-997. PubMed ID: 38752821
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).
    Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J
    Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil for "blue babies". Such unlicensed drug use might be justified as last resort.
    Oliver J; Webb DJ
    BMJ; 2002 Nov; 325(7373):1174. PubMed ID: 12433774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.